bpc-157 human dosing protocol (Common Protocols), ๐น Oral / Subcutaneous, โข 500 mcg daily, โข Duration: 6 weeks, ๐น Intramuscular / Peritendinous, โข 1 mg daily, โข Duration: 6 weeks, โ ๏ธ Note:, Not approved by FDA or bpc-157 dosing protocol human BPC-157
Description
The peptide works by dramatically increasing blood vessel formation in injured areas, essentially creating new highways for nutrients and oxygen to reach damaged tissues
Homocysteine, hypothyroidism, and effect of thyroid hormone replacement
The unit calculations for microdoses require extra precision because the volumes are extremely small
Unknown Drug Interactions Because BPC-157 is not FDA-approved, theres limited understanding of how it might interact with prescription drugs, anabolic steroids, or supplements
